The mitochondrial E3 ligase MAPL SUMOylates Drp1 to facilitate mitochondrial fission in intervertebral disc degeneration

Abstract

Intervertebral disc degeneration (IVDD) is the primary contributor to a range of spinal diseases. Dynamin-related protein 1 (Drp1)-mediated mitochondrial fission has recently been identified as a new cause of nucleus pulposus cell (NPC) death and IVDD, but the underlying mechanisms remain unclear. Although the effects of Drp1 phosphorylation in IVDD have been studied, it is currently unknown if small ubiquitin-like modifications (SUMOylation) of Drp1 regulate IVDD. This study aimed to investigate the functions and mechanisms of mitochondria-anchored protein ligase (MAPL), a mitochondrial SUMO E3 ligase, during IVDD progression. The expression of genes related to SUMOylation and mitochondrial dynamics in TNF-α-stimulated NPCs was analysed via RNA sequencing. The levels of total and mitochondrial SUMO1 conjugates were elevated with MAPL upregulation in TNF-α-treated NPCs. Additionally, mitochondrial fragmentation and dysfunction were induced by TNF-α stimulation. MAPL overexpression promoted mitochondrial SUMOylation and SUMO1 modification of Drp1, thereby facilitating the mitochondrial translocation of Drp1 and mitochondrial fission. MAPL-induced ROS accumulation and ΔΨm loss led to increased NPC apoptosis. Mutation of the SUMO-acceptor lysine residues of Drp1 hindered its SUMOylation and rescued the mitochondrial phenotypes caused by MAPL. SENP5 overexpression phenocopied MAPL silencing, negatively modulating the SUMO1 modification of Drp1 and mitochondrial fission in NPCs. In a rat IVDD model, forced expression of MAPL by using an adeno-associated virus (AAV) vector aggravated IVD tissue damage, whereas the knockdown of MAPL delayed IVDD progression. Our findings highlight the importance of SUMOylation in IVDD. The inhibition of MAPL-mediated Drp1 SUMOylation alleviates mitochondrial fission and limits IVDD development, providing a potential strategy for IVDD treatment.

References

[1] Mohd IsaIL, et al.. Intervertebral disc degeneration: biomaterials and tissue engineering strategies toward precision medicine. Adv. Healthcare Mater., 2022, 112102530

[2] QiM, et al.. Comparison of clinical outcomes between cervical disc arthroplasty and anterior cervical discectomy and fusion for the treatment of single-level cervical spondylosis: a 10-year follow-up study. Spine J., 2023, 23: 361-368

[3] WangZ, et al.. Inhibition of aberrant Hif1α activation delays intervertebral disc degeneration in adult mice. Bone Res., 2022, 102

[4] ChenZ, et al.. N6-methyladenosine hypomethylation of circGPATCH2L regulates DNA damage and apoptosis through TRIM28 in intervertebral disc degeneration. Cell Death Differ., 2023, 30: 1957-1972

[5] SongY, et al.. Mitochondrial quality control in intervertebral disc degeneration. Exp. Mol. Med., 2021, 53: 1124-1133

[6] BockFJ, TaitSWG. Mitochondria as multifaceted regulators of cell death.. Nat. Rev. Mol. Cell Biol., 2020, 21: 85-100

[7] QuilesJM, GustafssonB. The role of mitochondrial fission in cardiovascular health and disease.. Nat. Rev. Cardiol., 2022, 19: 723-736

[8] AnsariMY, NovakK, HaqqiTM. ERK1/2-mediated activation of DRP1 regulates mitochondrial dynamics and apoptosis in chondrocytes. Osteoarthr. Cartil., 2022, 30: 315-328

[9] WuD, TanB, SunY, HuQ. Cystathionine γ lyase S-sulfhydrates Drp1 to ameliorate heart dysfunction. Redox Biol., 2022, 58102519

[10] LinZ, et al.. Chondrocyte-targeted exosome-mediated delivery of Nrf2 alleviates cartilaginous endplate degeneration by modulating mitochondrial fission. J. Nanobiotechnol., 2024, 22281

[11] LinZ, et al.. The role of mitochondrial fission in intervertebral disc degeneration. Osteoarthr. Cartil., 2023, 31: 158-166

[12] VertegaalACO. Signalling mechanisms and cellular functions of SUMO. Nat. Rev. Mol. Cell Biol., 2022, 23: 715-731

[13] ChangHM, YehETH. SUMO: from Bench to Bedside. Physiol. Rev., 2020, 100: 1599-1619

[14] ZhangY, et al.. SENP3 suppresses osteoclastogenesis by De-conjugating SUMO2/3 from IRF8 in bone marrow-derived monocytes. Cell Rep., 2020, 30: 1951-1963

[15] FrankS, et al.. Regulation of matrixmetalloproteinase-3 and matrixmetalloproteinase-13 by SUMO-2/3 through the transcription factor NF-κB. Ann. Rheum. Dis., 2013, 72: 1874-1881

[16] GomarascaM, LombardiG, MaroniP. SUMOylation and NEDDylation in primary and metastatic cancers to bone. Front. Cell Dev. Biol., 2022, 10889002

[17] WangF, CaiF, ShiR, WeiJN, WuXT. Hypoxia regulates sumoylation pathways in intervertebral disc cells: implications for hypoxic adaptations. Osteoarthr. Cartil., 2016, 24: 1113-1124

[18] Figueroa-RomeroC, et al.. SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. FASEB J., 2009, 23: 3917-3927

[19] HenleyJM, CarmichaelRE, WilkinsonKA. Extranuclear SUMOylation in neurons. Trends Neurosci., 2018, 41: 198-210

[20] ZuninoR, BraschiE, XuL, McBrideHM. Translocation of SenP5 from the nucleoli to the mitochondria modulates DRP1-dependent fission during mitosis. J. Biol. Chem., 2009, 284: 17783-17795

[21] SongY, et al.. The NLRX1-SLC39A7 complex orchestrates mitochondrial dynamics and mitophagy to rejuvenate intervertebral disc by modulating mitochondrial Zn²⁺ trafficking. Autophagy, 2024, 20: 809-829

[22] SongY, et al.. SYNJ2BP ameliorates intervertebral disc degeneration by facilitating mitochondria-associated endoplasmic reticulum membrane formation and mitochondrial Zn²⁺ homeostasis. Free Radic. Biol. Med., 2024, 212: 220-233

[23] SunK, JingX, GuoJ, YaoX, GuoF. Mitophagy in degenerative joint diseases. Autophagy, 2021, 17: 2082-2092

[24] WangH, et al.. GDF11 inhibits abnormal adipogenesis of condylar chondrocytes in temporomandibular joint osteoarthritis. Bone Jt. Res., 2022, 11: 453-464

[25] GongZ, et al.. CircRREB1 mediates lipid metabolism related senescent phenotypes in chondrocytes through FASN post-translational modifications. Nat. Commun., 2023, 145242

[26] LiJ, et al.. Desumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway. Nat. Commun., 2018, 9143

[27] Neuspiel, N. et al. Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr. Biol.18, 102–108 (2008).

[28] BraschiE, ZuninoR, McBrideHM. MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission. EMBO Rep., 2009, 10: 748-754

[29] PrudentJ, et al.. MAPL SUMOylation of Drp1 stabilizes an ER/mitochondrial platform required for cell death. Mol. Cell, 2015, 59: 941-955

[30] Zunino, R., Schauss, A., Rippstein, P., Andrade-Navarro, M. & McBride, H.M. The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. J. Cell Sci.120, 1178–1188 (2007).

[31] PfirrmannCW, MetzdorfA, ZanettiM, HodlerJ, BoosN. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine, 2001, 26: 1873-1878

RIGHTS & PERMISSIONS

The Author(s)